2 Biotech Stocks That Could Make You Richer
Equity markets are deep in the red for the year, and so is the broader biotech industry. Vertex Pharmaceuticals is living proof that drugmakers do not necessarily need a diversified and deep lineup to be successful. Here's the catch: Vertex holds a monopoly in this area.